Furthermore, the expression of NLRP3 in CRC tissue serves as a poor prognostic factor [5,6], suggesting that the regulation of NLRP3 may hold therapeutic value for IBD and its related CRC. Here, NLRP3 is linked to colorectal carcinoma.